Thomson Medical Group Limited carries a market capitalization of 1.40B, placing it among publicly traded companies globally. Its enterprise value stands at 1.68B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.
| Market Cap | 1.40B |
| Enterprise Value | 1.68B |
Thomson Medical Group Limited trades at a trailing price-to-earnings ratio of 1,422.60.
| PE Ratio | 1,422.60 |
| PS Ratio | 7.33 |
| PB Ratio | N/A |
| P/TBV Ratio | N/A |
| P/FCF Ratio | 13.40 |
| P/OCF Ratio | 24.70 |
On an enterprise value basis, Thomson Medical Group Limited trades at an EV/EBITDA multiple of 44.92 and an EV/FCF ratio of 12.84. The EV/Sales ratio of 7.33 reflects the premium investors are willing to pay for the company's revenue stream, while the EV/EBIT multiple of 44.92 provides insight into valuation relative to core operating earnings.
| EV / Sales | 7.33 |
| EV / EBITDA | 44.92 |
| EV / EBIT | 44.92 |
| EV / FCF | 12.84 |
Thomson Medical Group Limited maintains a current ratio of 5.32, meaning it holds 5.3x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 272.78, indicating elevated leverage, while an interest coverage ratio of 1.46 demonstrates limited ability to service its debt obligations.
| Current Ratio | 5.32 |
| Quick Ratio | 2.21 |
| Debt / Equity | 272.78 |
| Debt / EBITDA | N/A |
| Interest Coverage | 1.46 |
Thomson Medical Group Limited posts a return on equity of -0.12 and a return on invested capital of 1.17.
| Return on Equity (ROE) | -0.12 |
| Return on Assets (ROA) | -0.22 |
| Return on Invested Capital (ROIC) | 1.17 |
| Return on Capital Employed (ROCE) | 0.08 |
| Revenue Per Employee | N/A |
| Employee Count | N/A |
| Inventory Turnover | 0.64 |
Over the trailing twelve months, Thomson Medical Group Limited has paid 11.52M in income taxes, reflecting an effective tax rate of 78.57.
| Income Tax | 11.52M |
| Effective Tax Rate | 78.57 |
Thomson Medical Group Limited's stock has gained approximately 23.25581% over the past 52 weeks. The 50-day moving average sits at 0.06, while the 200-day moving average is 0.06.
| Beta (5Y) | N/A |
| 52-Week Price Change | 23.25581% |
| 50-Day Moving Average | 0.06 |
| 200-Day Moving Average | 0.06 |
| Average Volume (20 Days) | N/A |
Over the trailing twelve months, Thomson Medical Group Limited generated 229.82M in revenue and converted that into -1.67M in net income, yielding earnings per share of 0.00. EBITDA reached 37.50M, while operating income came in at 37.50M.
| Revenue | 229.82M |
| Gross Profit | 181.98M |
| Operating Income | 37.50M |
| Pretax Income | 14.66M |
| Net Income | -1.67M |
| EBITDA | 37.50M |
| EBIT | 37.50M |
| Earnings Per Share (EPS) | 0.00 |
Thomson Medical Group Limited produced 68.20M in operating cash flow over the past twelve months. After subtracting -57.53M in capital expenditures, free cash flow totaled 10.67M - equivalent to 0.00 per share.
| Operating Cash Flow | 68.20M |
| Capital Expenditures | -57.53M |
| Free Cash Flow | 10.67M |
| FCF Per Share | 0.00 |
Thomson Medical Group Limited operates with a gross margin of 79.18, reflecting its pricing power and cost economics. The operating margin of 16.32 and net profit margin of -0.73 provide insight into operational efficiency.
| Gross Margin | 79.18 |
| Operating Margin | 16.32 |
| Pretax Margin | 6.38 |
| Profit Margin | -0.73 |
| EBITDA Margin | 16.32 |
The company's payout ratio of 116.19 indicates the proportion of earnings distributed to shareholders.
| Dividend Per Share | 0.00 |
| Dividend Yield | N/A |
| Payout Ratio | 116.19 |
| Shareholder Yield | 1.39 |
| FCF Yield | 7.46 |
Thomson Medical Group Limited posts an Altman Z-Score of 7.13, well above the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.
| Altman Z-Score | 7.13 |